Related Experiment Video
Updated: Jun 11, 2026
08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Gene therapy in haemophilia--going for cure?
1Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Summary
Gene transfer offers a novel approach for haemophilia treatment by enabling continuous expression of activated factor VII (FVII), overcoming limitations of traditional therapies and short-acting recombinant FVII. This method shows promise in preclinical animal models.
Area of Science:
- Hematology
- Gene Therapy
- Biotechnology
Background:
- Traditional haemophilia treatment involves factor replacement, which can lead to inhibitor development.
- Recombinant activated factor VII (FVII) is an alternative but has a short plasma half-life.
- Gene transfer presents a potential alternative for sustained haemostasis in coagulation disorders.
Purpose of the Study:
- To introduce the concept of continuous activated factor VII (FVII) expression via gene transfer for haemophilia treatment.
- To review existing safety and efficacy data for this gene therapy approach in animal models.
Main Methods:
- Review of preclinical studies involving gene transfer for activated FVII (FVII) expression.
- Analysis of safety and efficacy data from small and large animal models.
Main Results:
- Gene transfer demonstrated the potential for continuous expression of activated FVII.
- Preclinical data in animal models suggest promising safety and efficacy profiles for this approach.
Conclusions:
- Continuous expression of activated FVII through gene transfer is a novel therapeutic strategy for haemophilia.
- Further research and clinical trials are warranted to validate this approach in human patients.
More Related Videos
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:49What is Genetic Engineering?
Overview